Clinical Trial

Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment

Name: Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment — clinical trial record (NCT07361549)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LIGHT 2

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)

Trial Details

NCT Number	NCT07361549
Lead Sponsor	Daniel A Tonetti, MD
Conditions	Refractory Migraine, Headache
Enrollment	80 participants
Start Date	2026-03
Primary Completion	2030-12 (estimated)
Study Completion	2031-07 (estimated)
Updated on ClinicalTrials.gov	2026-01-23